Home / About Us / Meet Our Directors

Meet Our Directors

Keith Widdowson


Keith has lived and managed regional pharmaceutical businesses in South Africa, Australia and also Asia Pacific from Singapore. Prior to that, he managed global pharmaceutical exports for Fisons from the UK. More recently, he has worked for 3i providing industry expertise for life science investments in Europe. Keith is now involved in pharmaceutical business consultancy and funding, as well as business mentoring.

Yvonne Barnett

Yvonne has a BSc (Hons) in Biomedical Science and a PhD in Biochemistry and Genetics, she is Senior Pro Vice-Chancellor (Research) at Nottingham Trent University. She has active research interests in causes and mechanisms of cancer and ageing and has authored in excess of 100 peer-reviewed original research papers, attracted several million pounds of funding support for research from a range of funding agencies and has long-standing collaborations with Centres of Excellence worldwide.  Yvonne was founding Director of the University Alliance Doctoral Training Alliance in Applied Biosciences for Health, which is the topic of her address to the 2017 HUCBMS conference.

Ian Macdonald

Ian has B.Sc. and Ph.D degrees in Physiology from the University of London. He joined the University of Nottingham in 1977, was appointed Professor in 1991 and was Head of the School of Biomedical Sciences from 1997-2002. He is now Director of Research for the Faculty of Medicine. He is joint Editor of the International Journal of Obesity, a civilian advisor on nutrition to the UK Ministry of Defence, a member of the Food Standards Agency’s Scientific Advisory Committee on Nutrition, and President of the (UK) Nutrition Society.

Faz Chowdhury

Faz is CEO of Nemaura Pharma Limited. He originally trained as a pharmaceutical scientist, and subsequently completed a Masters in Microsystems and Nanotechnology at Cranfield University , and undertook Doctoral Research at the University of Oxford on nano-drug delivery. His experience in the Pharma Industry spans product development, manufacturing, technical and corporate management. He has numerous patents in the field of drug delivery devices and formulations.

Steve Clark

Steve is a shareholding director of several companies based in Northampton who manufacture and retail evacuation equipment and moving & handling devices into hospitals, care homes and other public buildings around the world.  He has more recently set up a new business Help2Export Ltd designed to assist small businesses, based in the East Midlands who have little or no export experience by signposting and mentoring, as required.  Prior to his work in the Life Sciences sector he had over 25 years experience in the Financial Services sector with a number of insurance companies, brokers and banks.

Peter Rose

Peter is the UK’s Managing Director of Maetrics Ltd., formerly High Edge Consulting, which he founded in 2002, to assist medical device manufacturers with their worldwide quality systems, regulatory affairs and microbiological audits & reviews. He is a lead auditor and a degree qualified microbiologist.
Having worked in the medical device industry for 20 years, Peter has a wealth of experience and knowledge in quality and regulatory affairs in the medical devices sector.

Carol Aries

Carol has a BSc (Hons) in Economics and Business Economics from Southampton University and an MBA from the Open University. Carol has over 25 years’ experience in the medical devices industry working in a variety of business roles including Sales and Marketing Management across both the UK and European markets, Strategic Business Development as a Six Sigma Black Belt, and Head of Strategic Partnerships supporting 3M to establish strong collaborative relationships with strategic organisations in the NHS. Carol’s knowledge of the NHS has been further advance through an industry secondment to the Department of Health working in the Innovations Division supporting the implementation of the Department of Health Innovation, Health and Wealth strategy.

Dave Mead

Dave is Director of IP & Business Development at Albumedix, has more than twenty years’ experience in the development of biopharmaceutical processes, technologies and products. He received his PhD in biotechnology from the University of Manchester. Prior to joining Albumedix, Dave worked at GSK, Novozymes and Delta Biotechnology; Dave has previously held a range of management positions in R&D, manufacturing and IP. He is currently the key driver of numerous licenses, acquisitions and collaboration deals whilst managing a strong business development team responsible for both in- and out-licensing of platform technologies, products and services dedicated to the drug development and delivery industries.

Dr Nik Kotecha

As Chief Executive Officer at Morningside Pharmaceuticals Ltd, Nik has utilised his passion for drug discovery, International Trade and providing quality, affordable healthcare to forge a highly successful career. Nik started his education at Newcastle; then he went on to do a PhD at Imperial College in London, towards the identification of Novel Molecules in Drug Discovery; finally further Doctorate work at Cambridge University. Nik has previously worked with GSK (formerly SB) and Roche Pharmaceuticals. Having worked in the development, manufacture and supply of pharmaceutical products for 25 years, Nik has a wealth of experience in quality and regulatory affairs. Nik is also the Chair of the International Trade Steering Group for the East Midlands Chamber of Commerce.

Professor Mike Hannay

Mike is Managing Director at the East Midlands Academic Health Science Network (EMAHSN) and Chair of the AHSN Network, he has more than 25 years’ experience of working in the pharmaceutical industry, with an excellent track record of building collaboration with healthcare and academia.
He joined EMAHSN in July 2016 from ThermoFisher Scientific, where he had worked since 2013 as Vice President for the UK BioPharma Services Division.
That role built upon his significant experience both nationally and internationally, including Vice President of Medicines Development at AstraZeneca.  In his role with EMAHSN, Mike leads the organisation in helping to address some of the biggest health challenges facing the region.  Mike is currently Chair of the National AHSN Network, a collaboration of England’s 15 AHSNs.